ArticleScientific reports2026
Proteomic profiling of bronchoalveolar lavage following human segmental endotoxin challenge-a potential exacerbation model.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Segmental lipopolysaccharide (LPS) challenge is a well-established method to induce airway inflammation in human lungs. Bronchoalveolar lavage (BAL) is typically used to capture molecular and cellular changes, allowing investigation of pulmonary inflammation and assessing drug efficacy. This study aimed to describe the proteomic profile of human BAL in the segmental LPS challenge model. Pre-challenge BAL was collected from ten healthy non-smoking participants, followed by segmental instillation of LPS (40 EU/kg) and saline in the contralateral lung as control. After 24 h, BAL was sampled from the challenged lung segments. Using the SomaScan platform, 1,500 proteins were analysed. As expected, no significant differences were found between pre-challenge and saline-challenged BAL. After LPS compared to saline challenge, 599 proteins such as IL-6, IL-8, MPO, MMP9, CRP, VWF, G-CSF and Eotaxin, were significantly upregulated and 4 proteins were downregulated in BAL. The most significant biological processes associated with upregulated proteins were “immune system process”, “response to external stimulus” and “response to chemical”. As expected, the LPS challenge triggered a strong pro-inflammatory response including proteome changes seen in acute exacerbations (AEs). Overall, this study provides a comprehensive analysis of the proteomic profile in BAL following LPS challenge and its similarities with AEs, contributing to a deeper understanding of this model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.